Ben-Tzvi Avraham sold TTNP
October 1, 2025 · Form 4 insider transaction
Ben-Tzvi Avraham sold 3,313 shares of TTNP, a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 7 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,313
Price
N/A
Total value
N/A
InsiderBen-Tzvi Avraham
Role—
CompanyTTNP
SecurityCommon Stock
Transaction codeD: Disposition to the issuer
Transaction dateOctober 1, 2025
Filing dateOctober 8, 2025
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Disposed of pursuant to the Merger and Contribution and Share Exchange Agreement, dated as of August 19, 2024 (the "Merger Agreement"), by and among Titan Pharmaceuticals, Inc. ("Titan"), Black Titan Corporation ("Black Titan"), TTNP Merger Sub, Inc., a direct wholly owned subsidiary of Black Titan ("Merger Sub") and TalenTec Sdn. Bhd, in exchange for 1 ordinary share of Black Titan common stock for each share of Titan common stock on the effective date of the merger (the "Merger").